Myriad Genetics | MYGN - Debt



Myriad Genetics reported $59.3M in Debt for its fiscal quarter ending in March of 2025.


Debt Change Date
Agilent USD 3.41B 86M Jul/2025
Becton, Dickinson and Co. USD 19.34B 71M Jun/2025
Bio-Rad Laboratories USD 1.41B 204.6M Jun/2025
Bruker USD 2.44B 321.5M Jun/2025
Danaher USD 17.36B 878M Jun/2025
Exact Sciences USD 2.32B 16.28M Jun/2025
Hologic USD 2.52B 8.5M Jun/2025
Illumina USD 2.6B 608M Jun/2025
J&J USD 52.25B 15.62B Mar/2025
Mettler Toledo International USD 2.18B 109.83M Jun/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Quest Diagnostics USD 6.38B 525M Jun/2025
Quidel USD 2.79B 293M Jun/2025
Repligen USD 533.72M 149.97M Jun/2025
Revvity USD 3.17B 17.91M Mar/2025
Standard Biotools USD 28.62M 28.32M Jun/2025
Thermo Fisher Scientific USD 34.19B 2.91B Mar/2025
Veracyte USD 50.5M 50.5M Mar/2025
Waters USD 1.54B 81.64M Jun/2025